IC-26
From Wikipedia, the free encyclopedia
|
IC-26
|
|
| Systematic (IUPAC) name | |
| 4-ethylsulfonyl-N,N-dimethyl-4,4-di(phenyl)butan-2-amine | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H27NO2S |
| Mol. mass | 345.499 |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
IC-26 (WIN 1161-3) is an analogue of the opioid analgesic methadone, where the carbonyl group has been replaced by the bioisosteric sulfone group.
Human and animal studies suggest that IC-26 is around the same potency as methadone,[1][2] although other studies have found its activity to be inconsistent between different patients, with consistent opioid activity only being seen at a dose several times that of methadone. IC-26 was assessed for its abuse potantial, but despite being found to have similar potential to methadone for development of dependence[3] it was never placed under international control as an illegal drug.
[edit] References
- ^ Daniel Lednicer. Central Analgetics. (1982), p194. ISBN 0-471-08314-3
- ^ Paul A J Janssen. Synthetic Analgesics Part 1: Diphenylpropylamines. Pergamon Press 1960. p161-163.
- ^ Wolbach AB, Fraser HF. Addiction Liability of I-C-26. UNODC Bulletin on Narcotics 1963 Vol 1

